Last reviewed · How we verify

NCT05317624: PRP

Ultrasound Guided Steroids Injection Versus PRP for Shoulder Pain Relief

Completed EARLY_PHASE1 Last updated 4 April 2023
What this trial tests

EARLY_PHASE1 trial testing Platelet rich plasma in Shoulder Pain in 60 participants. Completed in 1 February 2023.

Timeline
10 August 2021
Primary endpoint
1 November 2022
1 February 2023

Quick facts

Lead sponsorAlexandria University
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date10 August 2021
Primary completion1 November 2022
Estimated completion1 February 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 20 to 70, any sex, with Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison between effects of ultrasound guided platelet rich plasma injection versus steroids injection for pain relief in cases of partial rotator cuff tears

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet rich plasma

Trials testing the same drug.

Other recruiting trials for Shoulder Pain

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05317624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing